150 related articles for article (PubMed ID: 23242953)
1. A comparative study of FDG PET/CT and enhanced multi-detector CT for detecting liver metastasis according to the size and location.
Park JM; Kim IY; Kim SW; Lee SM; Kim HG; Kim SY; Shin HC
Ann Nucl Med; 2013 Apr; 27(3):217-24. PubMed ID: 23242953
[TBL] [Abstract][Full Text] [Related]
2. MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.
Dong A; Dong H; Wang Y; Gong J; Lu J; Zuo C
Clin Nucl Med; 2013 Feb; 38(2):e66-73. PubMed ID: 22996250
[TBL] [Abstract][Full Text] [Related]
3. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
[TBL] [Abstract][Full Text] [Related]
4. Colorectal liver metastasis after 90Y radioembolization therapy: pilot study of change in MDCT attenuation as a surrogate marker for future FDG PET response.
Tochetto SM; Töre HG; Chalian H; Yaghmai V
AJR Am J Roentgenol; 2012 May; 198(5):1093-9. PubMed ID: 22528898
[TBL] [Abstract][Full Text] [Related]
5. Comparison of preoperative whole-body positron emission tomography with MDCT in patients with primary colorectal cancer.
Akiyoshi T; Oya M; Fujimoto Y; Kuroyanagi H; Ueno M; Yamaguchi T; Koyama M; Tanaka H; Matsueda K; Muto T
Colorectal Dis; 2009 Jun; 11(5):464-9. PubMed ID: 18637927
[TBL] [Abstract][Full Text] [Related]
6. Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.
Pant V; Sen IB; Soin AS
Nucl Med Commun; 2013 Aug; 34(8):749-57. PubMed ID: 23689586
[TBL] [Abstract][Full Text] [Related]
7. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
[TBL] [Abstract][Full Text] [Related]
8. (18)F-FDG-PET/CT findings in pancreatic metastasis.
Hu S; Zhang J; Zuo C; Cheng C; Liu Q; Sun G
Radiol Med; 2015 Oct; 120(10):887-98. PubMed ID: 25795439
[TBL] [Abstract][Full Text] [Related]
9. Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma.
Park TG; Yu YD; Park BJ; Cheon GJ; Oh SY; Kim DS; Choe JG
Clin Nucl Med; 2014 Jan; 39(1):1-7. PubMed ID: 24335565
[TBL] [Abstract][Full Text] [Related]
10. Early bone marrow metastasis detection: the additional value of FDG-PET/CT vs. CT imaging.
Evangelista L; Panunzio A; Polverosi R; Ferretti A; Chondrogiannis S; Pomerri F; Rubello D; Muzzio PC
Biomed Pharmacother; 2012 Sep; 66(6):448-53. PubMed ID: 22902054
[TBL] [Abstract][Full Text] [Related]
11. Increased 18F-FDG Uptake on PET/CT is Associated With Poor Arterial and Portal Perfusion on Multiphase CT.
Hwang SH; Lee M; Lee N; Park S; Kim CK; Park MA; Yun M
Clin Nucl Med; 2016 Apr; 41(4):296-301. PubMed ID: 26756099
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.
Funicelli L; Travaini LL; Landoni F; Trifirò G; Bonello L; Bellomi M
Abdom Imaging; 2010 Dec; 35(6):701-7. PubMed ID: 19784697
[TBL] [Abstract][Full Text] [Related]
13. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19-9 levels in detecting recurrent pancreatic adenocarcinoma.
Hamidian Jahromi A; Sangster G; Zibari G; Martin B; Chu Q; Takalkar A; Shi R; Shokouh-Amiri H
JOP; 2013 Jul; 14(4):466-8. PubMed ID: 23846950
[TBL] [Abstract][Full Text] [Related]
15. Respiratory-gated ¹⁸F-FDG PET/CT for the diagnosis of liver metastasis.
Suenaga Y; Kitajima K; Aoki H; Okunaga T; Kono A; Matsumoto I; Fukumoto T; Tanaka K; Sugimura K
Eur J Radiol; 2013 Oct; 82(10):1696-701. PubMed ID: 23768610
[TBL] [Abstract][Full Text] [Related]
16. A new in vivo model to analyze hepatic metastasis of the human colon cancer cell line HCT116 in NOD/Shi-scid/IL-2Rγ(null) (NOG) mice by (18)F-FDG PET/CT.
Kawai K; Tamura K; Sakata I; Ishida J; Nagata M; Tsukada H; Suemizu H; Nakamura M; Abe Y; Chijiwa T
Oncol Rep; 2013 Feb; 29(2):464-8. PubMed ID: 23165994
[TBL] [Abstract][Full Text] [Related]
17. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy.
Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A
Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
[TBL] [Abstract][Full Text] [Related]
19. Improving the detection of small lesions using a state-of-the-art time-of-flight PET/CT system and small-voxel reconstructions.
Koopman D; van Dalen JA; Lagerweij MC; Arkies H; de Boer J; Oostdijk AH; Slump CH; Jager PL
J Nucl Med Technol; 2015 Mar; 43(1):21-7. PubMed ID: 25613334
[TBL] [Abstract][Full Text] [Related]
20. 18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: a pilot study.
Sharma P; Karunanithi S; Chakraborty PS; Kumar R; Seth A; Julka PK; Bal C; Kumar R
Nucl Med Commun; 2014 Dec; 35(12):1247-53. PubMed ID: 25171438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]